| parent | Genetics results | LP70194-3 |
| child | Allele name | LP62065-5 |
| child | Allelic state | LP69969-1 |
| child | Amino acid change | LP62062-2 |
| child | Amino acid change type | LP62063-0 |
| child | Amino acid marker assessed | LP71012-6 |
| child | DNA change | LP62061-4 |
| child | DNA change type | LP62077-0 |
| child | DNA marker assessed | LP69970-9 |
| child | DNA sequence variation identifier | LP66913-2 |
| child | DNA sequence variation display name | LP66914-0 |
| child | Drug efficacy analysis overall interpretation | LP66897-7 |
| child | Drug efficacy sequence variation interpretation | LP66894-4 |
| child | Drug metabolism sequence variation interpretation | LP69975-8 |
| child | Filler DNA analysis test identifier | LP69971-7 |
| child | Genetic disease analysis overall carrier interpretation | LP69974-1 |
| child | Genetic disease analysis overall interpretation | LP66901-7 |
| child | Genetic analysis summary report | LP66902-5 |
| child | Genetic disease assessed | LP66900-9 |
| child | Genetic disease sequence variation interpretation | LP69972-5 |
| child | Genetic knowledge reference | LP136541-2 |
| child | Genetic variant assessment | LP136540-4 |
| child | Genomic source class | LP66917-3 |
| child | Individual allele identifier | LP66903-3 |
| child | Medication assessed | LP66896-9 |
| child | Pharmacogenetic analysis report | LP66898-5 |
| child | Placer DNA analysis test identifier | LP66890-2 |
| child | Reason for study additional note | LP70577-9 |
| child | Reference nucleotide | LP136539-6 |
| child | Reference sequence alteration | LP69979-0 |
| child | Transcript reference sequence identifier | LP66891-0 |
| STATUS | ACTIVE |
| PartDisplayName | en-US | HL7.GENETICS |
| DisplayName | en-US | HL7 genetics |
LOINC Version: 2.81
FHIR